Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs.

[1]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.

[2]  M. Mezzetti,et al.  Interleukin-1 binds to specific receptors on human bronchial epithelial cells and upregulates granulocyte/macrophage colony-stimulating factor synthesis and release. , 1991, American journal of respiratory cell and molecular biology.

[3]  F. Luscinskas,et al.  Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules , 1991, The Journal of experimental medicine.

[4]  R. Schleimer,et al.  Do cytokines play a role in leukocyte recruitment and activation in the lungs? , 1991, The American review of respiratory disease.

[5]  C. Dinarello.  Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[6]  L. Allegra,et al.  Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. , 1991, The Journal of allergy and clinical immunology.

[7]  K. McIntyre,et al.  Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody , 1991, The Journal of experimental medicine.

[8]  R. Thompson,et al.  The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation. , 1991, The American journal of pathology.

[9]  C. Dinarello,et al.  A specific receptor antagonist for interleukin 1 prevents Escherichia coli‐induced shock in rabbits , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. Kelley.  Cytokines of the lung. , 1992, The American review of respiratory disease.

[11]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock , 1990, Nature.

[12]  R. Thompson,et al.  Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. , 1990, The Journal of clinical investigation.

[13]  M. T. Brewer,et al.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.

[14]  Robert C. Thompson,et al.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor , 1990, Nature.

[15]  J. Pujol,et al.  Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. , 1990, International archives of allergy and applied immunology.

[16]  G. Campbell,et al.  Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. , 1989, The American review of respiratory disease.

[17]  S. Matalon,et al.  Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. , 1989, The American journal of physiology.

[18]  A. Mantovani,et al.  Cytokines as communication signals between leukocytes and endothelial cells. , 1989, Immunology today.

[19]  P. Barnes,et al.  New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. , 1989, The Journal of allergy and clinical immunology.

[20]  K. Resch,et al.  Interleukin 1: more than a mediator between leukocytes. , 1988, Trends in pharmacological sciences.

[21]  C. McClain,et al.  Monokine-induced acute lung injury in rabbits. , 1987, Journal of applied physiology.

[22]  A. Capron,et al.  Regulation of IgE synthesis by macrophages expressing FcE-receptors: role of interleukin 1. , 1987, Clinical and experimental immunology.

[23]  J. Mead,et al.  Mechanics of respiration in unanesthetized guinea pigs. , 1958, The American journal of physiology.